Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Heart bypass patients get new hope: which pill best protects your new artery?

NCT ID NCT04310995

First seen Apr 15, 2026 · Last updated May 01, 2026 · Updated 3 times

Summary

This study compares three common heart medications (nicorandil, diltiazem, and isosorbide mononitrate) to see which one best prevents spasms in the new artery used during bypass surgery. About 150 adults who recently had coronary artery bypass grafting with a radial artery graft will take one of the three pills for 24 weeks. Researchers will check the graft's health with scans and track heart events over 5 years to find the most effective anti-spasm treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CORONARY ARTERY BYPASS GRAFT are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Ruijin Hospital Shanghai Jiaotong University School of Medicine

    Shanghai, 200025, China

Conditions

Explore the condition pages connected to this study.